SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Original Report: February 8, 2000
MEDIZONE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 2-93277-D
Nevada 87-0412648
(State of Incorporation) (I.R.S. Employer Identification No.)
144 Buena Vista, P.O. Box 742, Stinson Beach, California 94970
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (415) 868-0300
<PAGE>
ITEM 4. Changes in Registrant's Certifying Accountant.
On January 18, 2000, the Company appointed Jones Jensen & Co. ("Jones Jensen")
to replace Andersen & Andersen LLP ("Andersen") as independent auditors of the
Company for the fiscal year ending December 31, 1998 and subsequent periods.
The former accountants, Andersen, were dismissed June 30, 1998. This change was
required because Kevin R. Andersen, a principal in Andersen, accepted the
position of Chief Financial Officer of the Company in June 1998.
The report of Andersen on the Company's consolidated financial statements for
the years ended December 31, 1997 and 1996 contained no adverse opinion or
disclaimer of opinion and was not qualified or modified as to uncertainty, audit
scope or accounting principle, except that such report on the consolidated
financial statements included an explanatory paragraph with respect to the
Company being in the development stage and its having suffered recurring losses
which raise substantial doubt about its ability to continue as a going concern.
The decision to engage Jones Jensen as the Company's independent auditors was
approved by the Company's board of directors.
In connection with the audits for the years ended December 31, 1997 and 1996,
and through June 30, 1998, the Company had no disagreements with Andersen on any
matter of accounting principles or practices, financial statement disclosure, or
auditing scope or procedure, which disagreements if not resolved to the
satisfaction of Andersen would have caused it to make reference thereto in its
report on the consolidated financial statements for 1997 and 1996.
During the years ended December 31, 1997 and 1996, and through June 30, 1998,
there have been no reportable events (as defined in Item 304(a)(1)(v) of
Regulation S-K).
Andersen has provided to the Company a letter addressed to the Securities and
Exchange Commission stating that it has reviewed the disclosure provided in this
section of this report on Form 8-K and has no disagreement with the relevant
portions of this disclosure, pursuant to the requirements of Item 304(a)(3) of
Regulation S-K. A copy of such letter, dated February 29, 2000, is filed as an
Exhibit 16 to this report.
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits
16 Letter regarding change in certifying accountant
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
MEDIZONE INTERNATIONAL, INC.
(Registrant)
By:/s/ Edwin G. Marshall
Edwin G. Marshall, Chief Executive Officer
Date: March 1, 2000
February 29, 2000
Securities and Exchange Commission 450 5th Street, N.W.
Washington, D.C. 20549
To Whom It May Concern:
We have been furnished with a copy of the response to Item 4 of the Form 8-K, as
amended, dated February 8, 2000, filed by our former client Medizone
International, Inc. We agree with the statements made in response to that Item
insofar as they relate to our firm.
Very truly yours,
/s/ Andersen Andersen & Strong, L.C.
Andersen Andersen & Strong, L.C.
